Staying up to date on the most current migraine news articles on the internet is almost impossible... unless you know how to get everything automatically delivered to your inbox.
And then have ten hours a day to sift through it and read it all. Or... you can bookmark this page.
Let me save you some time... here are some new treatments I think you need to know about right now!
Calcitonin gene-related peptide or CGRP, the newest designer migraine drugs for treatment and prevention.
CGRP is a message carrying neurotransmitter chemical that can be measured in our blood. High levels are measured during an attack, and these new yet expensive drugs interfere and reduce the levels.
You can read all about it here - CGRP Drugs for Migraines.
The phase 3 trials are complete... and the anti-CGRP medications are getting approved... yay!
There are four currently available. Read more >>
On February 21, 2020, the Food and Drug Administration (FDA) approved Eptinezumab for use in the prevention of episodic and chronic Migraine attacks. Read more >>
THE first acute medication that works by blocking CGRP, Ubrelvy (ubrogepant) was approved by the FDA in December 2019. Read more >>
Migraine news articles and media are buzzing.
Just one week after the FDA approved Teva Pharmaceutical’s fremanezumab-vfrm (AJOVY™) for migraine treatment, Eli Lilly and Company announces U.S. Food and Drug Administration approval for their new anti-CGRP drug called galcanezumab (Emgality™). This makes it the third anti-CGRP treatment on the market that targets migraine treatment and prevention in adults. 
The dosing on this one is a little different. It begins with two "consecutive subcutaneous injections of 120 milligrams each as a loading dose, before beginning self-administered, monthly doses of 120 milligrams." The cost is still astronomical… the U.S. list price of galcanezumab is $575 once monthly, or $6,900 annually. But if you have the right commercial insurance, you might be eligible to receive the drug for up to 12 months free as part of Eli Lilly's patient-support program. 
The second new generation of the CGRP antibody called AJOVY™ was approved by the FDA on September 14th. This exciting bit of migraine news has us sufferers and the medical migraine world buzzing!
It is the first, and only anti-CGRP treatment available to patients in either quarterly (675 mg) or monthly (225 mg) dosing options. The prefilled syringe dose can be administered by you in your own home. Imagine that... no waiting 2 hours for the doctor! 
Make sure you have all your records and your migraine diary with your list of failed medications. In a recent article leading Migraine researcher and specialist Dr. Peter Goadsby said “If you don’t have your records, get them... I think the crucial thing [to prepare for the release of CGRP meds] is to carefully document what medications you have tried, because that’s the evidence that’s going to be used.” 
As with any new drug or treatment the price tag is usually beyond our means. The list price for Aimovig (erenumab) will be $6,900 a year, but the good news is it will be available next week. 
Here are some older migraine news articles... but still great ones.
Closer to a cure then we've ever been! Check out this news broadcast CT researcher at front line of breakthrough migraine research published Jan. 15, 2018.
A new prediction system may help to prevent migraine pain. It can tell you when one is coming. A m a z i n g !
The new drug-free wireless armband that is showing promise for migraine sufferers. It's in clinical trials now.
There is often a lot of news surrounding the connection between heart defects causing migraines in children. I recently had an ultrasound for this same heart defect, but the diagnosis was negative. They looked for bubbles in and around my heart walls, for something called a “patent foramen ovale” (PFO).
I was scared to think I might have to have heart surgery, but at the same time relieved to think I could somehow reduce the relentless 20 days per month migraine I suffered. I can’t even imagine having had these horrific headaches as a child. What a nightmare for both parent and child.
relatively current article that the Daily News and Analysis published on 31st
March, 2011 said that “roughly 15 percent of children suffer from
migraines” and they are severe in most cases.
If the recent studies can establish a link, then the heart defect can be corrected with the insertion of a catheter device bringing an end to children suffering with this as the cause of migraine.
I think the best way to stay up to date is to register for the Migraine World Summit.
Click on the image to read more about it.
You can watch it for free once each year, but if you've missed it, you can still sign up and wait until it rolls around again or buy the package now. Migraine treatments are being researched all over the world. Do you know what's new in Europe? You can stay on top of things by watching the summit. I get it each year for my own radical self care.
I take the whole week off to listen to the top advancements and migraine specialists to ensure I'm doing the right things to abort and prevent the next attack. This also ensures I pass on the most up to date information here on my website too. I don't want you to miss a thing.
Plus, I am supporting migraine education and research in my own little way.
Here are some more trustworthy links for you to gather recent migraine news articles every day.
AND... remember to bookmark this page for the latest migraine news from around the world.
Stay well and be pain free,
Migraine News Articles Sources:
1. Fowler, E. (2018) Want To Try Aimovig? 4 Keys For Accessing New Migraine Treatments. Available [online] at: https://migraineagain.com/4-steps-access-new-migraine-treatments/
2. American Migraine Foundation (2018) FDA Approves Second Anti-CGRP Treatment for Migraine. Available [online] at: https://americanmigrainefoundation.org/understanding-migraine/fda-approves-second-anti-cgrp-treatment-for-migraine/
3. American Migraine Foundation (2018) 3rd Anti-CGRP Treatment Approved for Migraine. Available [online] at: https://americanmigrainefoundation.org/understanding-migraine/galcanezumab-Emgality-anti-cgrp-treatment-approved-for-migraine/
4. The Migraine World Summit
5. Migraine Again (2020) VYEPTI for Migraine Prevention Approved by FDA. Available [online] at: https://migraineagain.com/new-vyepti-for-migraine-prevention-approved-by-fda/